Regulation of TGFβ1-mediated Collagen Formation by LOX-1: Studies Based on Forced Overexpression of TGFβ1 in Wild-Type and Lox-1

Changping Hu,Abhijit Dandapat,Liuqin Sun,Junaid A. Khan,Yong Liu,Paul L. Hermonat,Jawahar L. Mehta

DOI: https://doi.org/10.1074/jbc.M708820200

IF: 5.485

2008-01-01

Journal of Biological Chemistry

Abstract:Transforming growth factor β1 (TGFβ1) activation leads to tissue fibrosis. Here, we report on the role of LOX-1, a lectin-like 52-kDa receptor for oxidized low density lipoprotein, in TGFβ1-mediated collagen expression and underlying signaling in mouse cardiac fibroblasts. TGFβ1 was overexpressed in wild-type (WT) and LOX-1 knock-out mouse cardiac fibroblasts by transfection with adeno-associated virus type 2 vector carrying the active TGFβ1 moiety (AAV/TGFβ ACT1). Transfection of WT mouse cardiac fibroblasts with AAV/TGFβ ACT1 markedly enhanced the expression of NADPH oxidases (p22phox, p47phox, and gp91phox subunits) and LOX-1, formation of reactive oxygen species, and collagen synthesis, concomitant with an increase in the activation of p38 and p44/42 mitogen-activated protein kinases (MAPK). The TGFβ1-mediated increase in collagen synthesis was markedly attenuated in the LOX-1 knock-out mouse cardiac fibroblasts as well as in WT mouse cardiac fibroblasts treated with a specific anti-LOX-1 antibody. Treatment with anti-LOX-1 antibody also reduced NADPH oxidase expression and MAPK activation. The NADPH oxidase inhibitors and gp91phox small interfering RNA reduced LOX-1 expression, MAPK activation, and collagen formation. The p38 MAPK inhibitors as well as the p44/42 MAPK inhibitors reduced collagen formation without affecting LOX-1 expression in cardiac fibroblasts. These observations suggest that collagen synthesis in cardiac fibroblasts involves a facilitative interaction between TGFβ1-NADPH oxidase and LOX-1. Further, the activation of MAPK pathway appears to be downstream of TGFβ1-reactive oxygen species-LOX-1 cascade.